Oncology
Hello, Suzanne Dixon
Manage E-mail  |  Logout

Article ID

Home
General Oncology
Messages (38)
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Need hemophilia CME? Here’s the latest, straight from ISTH 2009 in Boston, with expert commentary on the topics you...
Victoria Luken, MDLinx CME
FDA Update: Bevacizumab + Interferon Alfa Approved for Renal Cell Carcinoma
Tracy Hampton, PhD, MDLinx Oncology
HHS Weighs In On Health Reform
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Myeloproliferative Dz



Latest (6) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group
Leukemia Research, 08/21/09
Sponsor
Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research, 08/20/09
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS)
Blood, 08/12/09
Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to –7/del(7q) MDS
Cancer Genetics and Cytogenetics, 08/11/09
The molecular characterization and clinical management of multiple myeloma in the post-genome era
Leukemia, 08/11/09
Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis
Journal of Clinical Oncology, 08/10/09
Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm
Human Pathology, 08/10/09
Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma
Journal of Clinical Oncology, 08/07/09
Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma
Blood, 08/06/09
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Clinical Cancer Research, 08/04/09
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes
American Journal of Hematology, 08/04/09
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
Blood, 08/03/09
Differential repetitive DNA methylation in multiple myeloma molecular subgroups
Carcinogenesis, 07/31/09
Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure
British Journal of Haematology, 07/30/09
Vorinostat in solid and hematologic malignancies
Journal of Hematology & Oncology, 07/29/09
Endothelial colony forming cells (ECFCs) from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker
Blood, 07/28/09
Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes
Seminars in Hematology, 07/27/09
Clinical and immunological evaluation of zoledronate-activated Vgamma9gamma delta T-cell-based immunotherapy for patients with multiple myeloma
Experimental Hematology, 07/27/09
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets
Experimental Hematology, 07/27/09
Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subset
Experimental Hematology, 07/27/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
188 Available Pages
First    Prev    7      8      9      10      11      12      13      14      15      16      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.